Prospective Interventional Study on Reversibility of Type 2 Diabetes Mellitus With Hypocaloric Diet

Prospective Interventional Study on Reversibility of Type 2 Diabetes Mellitus With Hypocaloric Diet

Prospective Interventional Study on Reversibility of Type 2 Diabetes Mellitus With Hypocaloric Diet

Recruiting
20-84 years
All
Phase 1
The objective is to study the effect of LCD in anthropometric , biochemical and NAFLD (Non Alcholic Fatty Liver Disease) parameters after 8 weeks and 24 weeks from enrollment.
Purposive sampling is used to enroll participants in the study. The LCD is a combination of one meal replacer and modified major meals. Calculated exchanges of food groups is taken care of in the other two major meals and snacks in between. Inorder to adhere compliance clinical (at baseline, after 8 weeks, after 24 weeks) as well as virtual visits through whatsapp, e-mails, SMS, phone calls (once a week during 8 weeks of intervention and further once a month upto 24 weeks) are scheduled. After 8 weeks of LCD, calorie is increased to 1200-1400 Kcal/day. In the control group the standard medical treatment is continued.
The data is collected in case report form and analysed using SPSS software by statistician.
Study details
    Diabetes Mellitus Types I and II
    diabeties

NCT912489

Max Healthcare Insititute Limited

28 September 2026

Step 1

Check your eligibility to see if you may qualify for this clinical study

Clinical Study Eligibility Questionnaire

Thank you for your interest in learning more about this clinical study.

Please take a few minutes to complete this eligibility questionnaire. The questions will ask about your symptoms, medical history, and other basic health information that may be relevant to the study.

  1. Your responses will be reviewed to help determine whether you may meet the initial eligibility criteria for this clinical study.
  2. Based on the information you provide, you may be guided to the next steps if your responses indicate that you could be a potential match for the study.

Please answer each question as accurately and completely as possible. Completing this questionnaire does not guarantee eligibility or participation in the clinical study. Final eligibility will be determined by the study team based on the complete study requirements and any additional assessments that may be needed.

If you appear to be a potential match, you will be provided with information about the next steps and how you can learn more about participating in the study.

Estimated time: A few minutes to complete.

Pfizer Privacy Policy U.S.


Preview complete

The prescreener preview is complete. You may now close the preview.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.